Investors Urged to Contact Levi & Korsinsky For Information Before August 25, 2025 – Hims & Hers Health, Inc. (HIMS)

NEW YORK, NY / ACCESS Newswire / July 31, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=159142&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at […]

ERES Provides Update on Previously Disclosed Disposition, Announces EUR53 Million in Additional Dispositions and Distribution Update

(TSX:ERE-UN),(TSX:ERE.UN), TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (“ERES” or the “REIT“) (TSX:ERE.UN) announced today an update on the expected timing of its previously disclosed disposition, and its anticipated special distribution, as disclosed in its press release dated April 2, 2025. ERES also announced approximately EUR52.8 million in additional

ERES Provides Update on Previously Disclosed Disposition, Announces EUR53 Million in Additional Dispositions and Distribution Update

ERES Provides Update on Previously Disclosed Disposition, Announces EUR53 Million in Additional Dispositions and Distribution Update GlobeNewswire July 31, 2025 TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (“ERES” or the “REIT“) (TSX:ERE.UN) announced today an update on the expected timing of its previously disclosed disposition, and its anticipated special

Stellus Capital Investment Corporation Schedules Second Quarter 2025 Financial Results Conference Call

Stellus Capital Investment Corporation (NYSE: SCM) will release its financial results for the second quarter ended June 30, 2025 on Wednesday, August 6, 2025, after the close of the stock market. Stellus Capital Investment Corporation will host a conference callto discuss these results on Thursday, August 7, 2025 at 10:00 AM, Central Time. The conference

Graphic Packaging Holding Company Declares Quarterly Dividend

Graphic Packaging Holding Company (NYSE: GPK), a global leader in sustainable consumer packaging, today announced that its Board of Directors declared a quarterly dividend of $0.11 per share of common stock to stockholders of record at the close of business on September 15, 2025. The dividend is payable on October 5, 2025. https://mma.prnewswire.com/media/1996929/GPI_Logo.jpg ContactInvestors: Investor.Relations@graphicpkg.com

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund Investors to Secure Counsel Before Important Deadline in Securities Class Action – RMJAX, RMHVX, RMHIX

NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of shares of the Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund (the "Fund") (tickers: RMJAX, RMHVX, RMHIX), between May 5, 2023 and June 12,

Encouraging Reviews on Dealership Websites: Best Practices and How DealerFire Can Help

Dealerships Can Improve Credibility with Customer Reviews Online reviews are one of the most influential factors in the car-buying journey, often shaping a customer's decision before they even step onto a dealership lot. Recognizing the value of customer feedback,DealerFire is highlighting several effective strategies dealerships can use to increase their volume of positive reviews and

IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million

IM Cannabis Corp. (“IM Cannabis” or the “Company”) (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, effective July 30, 2025 (the “Closing Date”) it has closed a private placement offering (the “Offering”), through the issuance of 2,050,000 units (each a “Unit”) at a price per

FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors

— FDA approval is based on phase 3 trial data (explorer8), which established the safety and efficacy of Alhemo® (concizumab-mtci) injection in people 12 years and older with hemophilia A or B (HA/HB) without inhibitors1 — Results showed a 79% reduction in annualized bleeding rate (ABR) in patients with HB without inhibitors and an 86%

Pharmacy Profiles partners with Delaware Pharmacy Society to provide credentials verification services

Pharmacy Profiles is proud to announce a new partnership with the Delaware Pharmacy Society to deliver comprehensive credentials verification services for pharmacy professionals across the state. This collaboration underscores a shared commitment to ensuring the highest standards of professional practice and patient care. https://mma.prnewswire.com/media/2742276/Pharmacy_Profiles_Logo.jpg Through this agreement, Delaware Pharmacy Society members will benefit from streamlined

Scroll to Top